Sensus Healthcare, Inc.

Overview

"How the company got here" "Sensus Healthcare was founded in 2010 with the goal of providing effective, non-invasive treatments for skin conditions. The company developed and patented Superficial Radiation Therapy (SRT), a low-energy X-ray technology. This innovation offered a new, non-surgical alternative for treating non-melanoma skin cancers and other skin issues like keloids. Sensus Healthcare has since focused on refining its SRT technology and expanding its reach to healthcare providers globally. The company's journey has been marked by continuous research and development to improve its treatment devices and secure their place in the medical device market. Sensus Healthcare aims to make SRT the primary treatment option for skin cancer." "What it actually does" "Sensus Healthcare designs, manufactures, and sells medical devices that use a specialized form of radiation therapy called Superficial Radiation Therapy (SRT). This technology uses low-energy X-rays to treat various skin conditions, primarily non-melanoma skin cancers, such as basal cell and squamous cell carcinomas. It also offers a treatment for keloids, which are raised scars. The company's devices provide a non-surgical option for patients, aiming to be effective while minimizing cosmetic impact and patient discomfort. Sensus Healthcare markets its products to private dermatology practices and radiation oncologists." "SRT-100 Systems" "This is the core business for Sensus Healthcare, involving the sale of their Superficial Radiation Therapy (SRT) devices. These machines, like the SRT-100, SRT-100 Vision, and SRT-100 Plus, deliver low-energy X-rays to treat non-melanoma skin cancers and keloids. Healthcare providers, such as dermatologists and oncologists, purchase these systems to offer a non-surgical treatment option to their patients. This segment represents the primary way the company generates revenue, with sales of these devices forming the bulk of its business." "Ancillary Products and Services" "Beyond the main SRT treatment systems, Sensus Healthcare also generates revenue from related products and services. This includes selling disposable items like lead shielding replacements, radiation safety items such as aprons and eye shields, and applicator tips used with the SRT devices. The company also offers a 'Sentinel service program' which provides protection and maintenance for their systems, ensuring they function correctly. Additionally, they distribute laser devices for aesthetic treatments and provide operational support services to dermatology clinics, diversifying their income streams." "What management is betting on now" "Sensus Healthcare's management is focused on several key priorities to drive future growth and profitability. They are emphasizing customer adoption of their SRT technology and expanding their commercial reach, both domestically and internationally. A significant focus is on building recurring revenue streams, possibly through service agreements and other ongoing customer relationships. Management is also prioritizing profitability, aiming to achieve it by leveraging attractive reimbursement codes for SRT, diversifying their customer base, and maintaining tight control over expenses. They are also exploring new international markets, particularly in Asia-Pacific and Australia, to broaden their global presence."